Insider · CIK 0001298814

Fanucci Marsha

Reports to the SEC for 8 companies · SOMERVILLE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001298814

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-26	GENBGenerate Biomedicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+29.6K sh	—	—	29,561
2024-06-05	Syros Pharmaceuticals, Inc.A Award	Director	AAward	+4,000 sh	—	—	16,000
2024-06-05	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2023-06-01	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2023-06-01	Syros Pharmaceuticals, Inc.A Award	Director	AAward	+4,000 sh	—	—	12,000
2023-05-18	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+3,454 sh	—	—	3,454
2023-02-23	ALNYALNYLAM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−136 sh	—	—	0
2023-02-23	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+136 sh	—	—	136
2022-10-14	Forma Therapeutics Holdings, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−28.1K sh	—	—	0
2022-10-14	Forma Therapeutics Holdings, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,375 sh	—	—	0
2022-10-14	Forma Therapeutics Holdings, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,750 sh	—	—	0
2022-10-14	Forma Therapeutics Holdings, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−14K sh	—	—	0
2022-10-14	Forma Therapeutics Holdings, Inc.U Disposition from Tender	Director	UDisposition from Tender	−52.5K sh	—	—	0
2022-10-14	Forma Therapeutics Holdings, Inc.U Disposition from Tender	Director	UDisposition from Tender	−7,250 sh	—	—	0
2022-10-14	Forma Therapeutics Holdings, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17.5K sh	—	—	0
2022-09-16	Syros Pharmaceuticals, Inc.A Award	Director	AAward	+8,000 sh	—	—	8,000
2022-09-16	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2022-06-14	KRSAKorsana Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2022-06-08	Forma Therapeutics Holdings, Inc.A Award	Director	AAward	+4,500 sh	—	—	59,782
2022-06-08	Forma Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+6,750 sh	—	—	6,750
2022-06-01	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2022-05-18	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+5,153 sh	—	—	5,153
2022-02-23	ALNYALNYLAM PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+136 sh	—	—	136
2021-07-15	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+4,032 sh	—	—	4,032
2021-06-24	KRSAKorsana Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-06-17	Forma Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+8,375 sh	—	—	8,375
2021-06-17	Forma Therapeutics Holdings, Inc.A Award	Director	AAward	+2,750 sh	—	—	55,282
2021-06-08	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2020-07-01	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+4,581 sh	—	—	4,581
2020-06-23	Forma Therapeutics Holdings, Inc.S Sale	Director	SSale	−10.2K sh	—	—	0
2020-06-23	Forma Therapeutics Holdings, Inc.S Sale	Director	SSale	−14K sh	—	—	0
2020-06-23	Forma Therapeutics Holdings, Inc.S Sale	Director	SSale	−33.8K sh	—	—	0
2020-06-23	Forma Therapeutics Holdings, Inc.P Purchase	Director	PPurchase	+52.5K sh	—	—	52,532
2020-06-23	Forma Therapeutics Holdings, Inc.S Sale	Director	SSale	−9,847 sh	—	—	0
2020-06-18	Forma Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+17.5K sh	—	—	0
2020-06-16	KRSAKorsana Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2020-06-11	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2019-11-20	ALNYALNYLAM PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−30K sh	—	—	0
2019-11-20	ALNYALNYLAM PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2019-11-20	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2019-11-20	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2019-11-20	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+30K sh	$9.14	+$274K	30,000
2019-11-20	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$11.33	+$170K	60,000
2019-11-20	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$9.30	+$140K	45,000
2019-11-20	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$30.09	+$451K	75,000
2019-11-20	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−75K sh	$100.00	−$7.5M	0
2019-07-01	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2019-06-11	Syros Pharmaceuticals, Inc.Common Stock (right to buy)A Award	Director	AAward	+11K sh	—	—	11,000
2019-06-01	KRSAKorsana Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2019-04-01	KRSAKorsana Biosciences, Inc.A Award	Director	AAward	+13.7K sh	—	—	13,671

Recent filings

Accepted (ET)
Mar 24
Fanucci Marsha0001193125-26-085871
SEC(opens sec.gov)
Jun 74
Fanucci Marsha0000950170-24-070711
SEC(opens sec.gov)
Jun 24
Fanucci Marsha0001209191-23-033723
SEC(opens sec.gov)
May 194
Fanucci Marsha0001735276-23-000061
SEC(opens sec.gov)
Feb 274
Fanucci Marsha0001735276-23-000016
SEC(opens sec.gov)
Oct 144
Fanucci Marsha0000899243-22-033658
SEC(opens sec.gov)
Sep 194
Fanucci Marsha0001209191-22-050554
SEC(opens sec.gov)
Jun 164
Fanucci Marsha0001140361-22-023333
SEC(opens sec.gov)
Jun 94
Fanucci Marsha0000899243-22-021660
SEC(opens sec.gov)

Companies

Address

GENERATE BIOMEDICINES, INC. 101 SOUTH STREET, SUITE 900

SOMERVILLE, MA, 02143